| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |